• Immunohistochemistry analysis of paraffin-embedded rectum cancer tissues (left) and lung cancer tissues (right) with DAB staining using Cytokeratin 19 monoclonal antibody.
  • Anti-KRT19 antibody [1H6] (STJ97987)
  • Western blot analysis using Cytokeratin 19 monoclonal antibody against T47D (1) , MCF-7 (2) , SKBR-3 (3) , HepG2 (4) , Caco-2 (5) and SW620 (6) cell lysate.

Anti-KRT19 antibody [1H6] (STJ97987)

SKU:
STJ97987

Current Stock:
Host: Mouse
Applications: WB/IHC/IF/ELISA
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-Keratin, type I cytoskeletal 19 is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Monoclonal
Clone ID: 1H6
Conjugation: Unconjugated
Isotype: IgG1
Formulation: Liquid in PBS containing 0.03% Sodium Azide, 0.5% BSA, 50% Glycerol.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
IHC 1:200-1:1000
ELISA 1:10000
IF 1:50-200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: KRT19
Gene ID: 3880
Uniprot ID: K1C19_HUMAN
Specificity: Cytokeratin 19 Monoclonal Antibody detects endogenous levels of Cytokeratin 19 protein.
Immunogen: Purified recombinant fragment of human Cytokeratin 19 expressed in E. Coli.
Function Involved in the organization of myofibers. Together with KRT8, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle.
Protein Name Keratin - Type I Cytoskeletal 19
Cytokeratin-19
Ck-19
Keratin-19
K19
Database Links Reactome: R-HSA-6805567
Reactome: R-HSA-6809371
Alternative Antibody Names Anti-Keratin - Type I Cytoskeletal 19 antibody
Anti-Cytokeratin-19 antibody
Anti-Ck-19 antibody
Anti-Keratin-19 antibody
Anti-K19 antibody
Anti-KRT19 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance